Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20215384 20155553 1.8 114.4 Palliative (P) 2019-05-26 2019-08-31 EOX 02 N EOX 100170904
20215385 20155554 1.91 75.9 Palliative (P) 2019-08-22 2019-09-04 Trial Unspecified 02 N TRIAL 100386693
20215389 20155555 1.82 76 Neo-adjuvant (N) 2019-02-06 2019-02-14 null 02 N CETUXIMAB + IRINOTECAN + MDG 101009639
20215390 20155556 1.76 62.8 null 2018-12-15 2018-12-29 CETUXIMAB + IRINOTECAN + MDG 2 N CETUXIMAB + IRINOTECAN + MDG 100711634
20215397 20155557 1.71 73.1 Palliative (P) 2020-02-20 2020-02-28 EOX N null CETUXIMAB + IRINOTECAN + MDG 100150669
20215400 20155558 1.63 null Palliative (P) 2018-06-29 2018-06-29 Sorafenib 02 N SORAFENIB 101715243
20215403 20155559 1.62 67 Curative (C) 2017-05-21 2017-05-21 Capecitabine 35days + RT N Y EOX 100550894
20215404 20155560 1.74 0 Palliative (P) 2020-05-14 2020-05-28 CETUXIMAB + IRINOTECAN + MDG 99 N CETUXIMAB + IRINOTECAN + MDG 101527618
20215413 20155561 1.76 60.5 Curative (C) 2017-01-12 2017-02-20 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100988285
20215415 20155562 1.79 48.6 null null null EOX 02 N SORAFENIB 100805659
20215417 20155563 1.88 62.7 Palliative (P) 2018-12-17 2019-04-14 EOX 02 N OXALIPLATIN + RALTITREXED 101228387
20215419 20155564 1.8 null Neo-adjuvant (N) 2020-07-15 2020-09-03 Capecitabine 35days + RT 02 N CAPECITABINE + RT 101006178
20215420 20155565 1.8 120.5 Palliative (P) 2016-06-29 2016-07-11 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101365679
20215421 20155566 1.76 67.5 Adjuvant (A) 2018-04-22 2018-09-15 Capecitabine 35days + RT 02 N CAPECITABINE + RT 100835833
20215422 20155567 1.8 68.2 null 2018-03-01 2018-09-21 EOX 02 null OXALIPLATIN + RALTITREXED 100248825
20215424 20155568 1.69 54.55 null 2019-03-17 2019-03-19 EOX 99 N CETUXIMAB + IRINOTECAN + MDG 100294122
20215429 20155569 1.87 66.4 Palliative (P) null null Capecitabine 35days + RT 02 N CAPECITABINE + RT 100115985
20215430 20155570 1.55 54.8 null 2017-05-31 2017-06-03 EOX N null CETUXIMAB + IRINOTECAN + MDG 101228771
20215431 20155571 1.66 50.3 null 2018-10-17 2019-02-06 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101336993
20215433 20155572 1.78 null null 2019-05-13 2019-09-04 EOX 02 null SORAFENIB 100254615
20215437 20155573 1.82 72 null 2017-01-01 2017-01-02 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100782167
20215438 20155574 1.66 null Adjuvant (A) 2019-08-28 2019-11-06 Sorafenib 02 N SORAFENIB 101292259
20215442 20155575 1.81 76.5 Adjuvant (A) 2021-07-11 2021-07-24 EOX 02 N EOX 101053406
20215444 20155576 1.64 74 Palliative (P) 2019-03-29 2019-06-14 EOX 2 N EOX 101141866
20215445 20155577 1.49 66.1 Palliative (P) 2019-07-08 2019-07-24 EOX N N CETUXIMAB + IRINOTECAN + MDG 101363802
20215448 20155578 1.69 48 Adjuvant (A) 2017-10-15 2018-03-30 Capecitabine 35days + RT 02 Y CAPECITABINE + RT 100187902
20215449 20155579 0 80.3 Neo-adjuvant (N) 2019-10-12 2019-10-19 Cetuximab + Oxaliplatin + MdG Maint N Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101045602
20215456 20155580 0 71.9 Palliative (P) 2017-06-25 2017-10-18 Cetuximab + FOLFIRI cycle1 2 N CETUXIMAB + IRINOTECAN + MDG 101563720
20215466 20155581 1.72 74.7 Palliative (P) 2018-06-07 2018-06-21 CETUXIMAB + IRINOTECAN + MDG 99 N CETUXIMAB + IRINOTECAN + MDG 101865156
20215467 20155582 1.58 62.8 Palliative (P) 2019-07-24 2020-03-11 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101059272
20215475 20155583 1.84 80 Palliative (P) 2019-09-03 2019-09-10 Trial Unspecified Y N TRIAL 101253268
20215477 20155584 1.75 70 Palliative (P) 2018-07-06 2018-08-29 Sorafenib 02 null SORAFENIB 101631356
20215483 20155585 1.72 57.3 Palliative (P) 2019-03-05 2019-03-07 EOX 02 Y EOX 101002288
20215484 20155586 1.63 46.8 Palliative (P) 2017-06-09 2018-01-27 Cetuximab + FOLFIRI cycle 2 onwards 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100994397
20215488 20155587 1.72 76.4 null 2017-01-20 2017-02-18 CAPECITABINE + RT 02 null CAPECITABINE + RT 100712956
20215490 20155588 1.89 108 null 2017-08-28 2017-09-16 IRINOTECAN + MDG + PANITUMUMAB 01 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101320273
20215493 20155589 1.62 60.4 Palliative (P) 2018-05-25 2018-06-11 CAPECITABINE + RT 99 N CAPECITABINE + RT 101329471
20215499 20155590 1.51 40.4 Curative (C) 2022-01-05 2022-01-12 Oxaliplatin + Raltitrexed 02 Y OXALIPLATIN + RALTITREXED 100580590
20215505 20155591 1.74 94 Neo-adjuvant (N) 2017-02-06 2017-02-21 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101360998
20215507 20155592 1.69 92 Palliative (P) null 2018-01-24 EOX 2 N EOX 101337926
20215513 20155593 1.83 92.8 Palliative (P) 2020-06-02 2020-06-05 Sorafenib 02 N SORAFENIB 101683326
20215523 20155594 1.91 85 Neo-adjuvant (N) 2017-06-10 2017-06-22 Sorafenib 02 N SORAFENIB 101113970
20215525 20155595 1.85 117 Neo-adjuvant (N) 2021-01-16 2021-01-24 CAPECITABINE + RT 02 N CAPECITABINE + RT 101541250
20215527 20155596 1.91 71.4 Palliative (P) 2016-05-24 2016-08-07 EOX 02 N OXALIPLATIN + RALTITREXED 101021453
20215528 20155597 1.93 95 Palliative (P) 2020-01-30 2020-11-04 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101016726
20215533 20155598 1.43 111.3 Adjuvant (A) 2017-08-11 2017-08-12 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100072129
20215534 20155599 0 54.3 Neo-adjuvant (N) 2019-09-27 2019-10-16 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100896720
20215538 20155600 1.6 67.5 Neo-adjuvant (N) 2022-04-17 2022-04-30 EOX 02 N EOX 100290366
20215539 20155601 0 79 Palliative (P) 2019-03-14 2019-03-14 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101700433
20215540 20155602 1.78 61.4 Palliative (P) 2018-02-15 2018-03-07 FLUOROURACIL + IRINOTECAN + Panitumumab 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101205920